Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dignass

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|July 17, 2013
Letter: inflammatory bowel disease guidelines and conflicts of interestR Eliakim, A Dignass, S Travis
Alimentary Pharmacology & Therapeutics|May 7, 2015
Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy--authors' replyH Schulze, P Esters, A Dignass
Journal of Crohn'S & Colitis|October 31, 2019
Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel DiseaseAyşegül Aksan, M Wohlrath, Tariq H Iqbal, et al.
Transplantation Proceedings|March 31, 2004
CMV, EBV, HHV6, and HHV7 infections after intestinal transplantation without specific antiviral prophylaxisA Pascher, J Klupp, R J Schulz, et al.
Alimentary Pharmacology & Therapeutics|September 8, 2017
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' replyA Aksan, H Işık, H H Radeke, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2017
Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel diseaseA Aksan, H Işık, H H Radeke, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2017
Editorial: which iron preparation for patients with IBD? Authors' replyA Aksan, H Işık, H H Radeke, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2017
Letter: inconsistency in reporting of hypophosphataemia after intravenous iron-authors' replyA Aksan, H Işık, H H Radeke, et al.
Gastroenterology|May 1, 1995
Delivery and fate of oral mesalamine microgranules within the human small intestineP H Layer, H Goebell, J Keller, et al.
The Journal of Clinical Investigation|July 1, 1994
Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathwayA Dignass, K Lynch-Devaney, H Kindon, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|July 17, 2013
Letter: inflammatory bowel disease guidelines and conflicts of interestR Eliakim, A Dignass, S Travis
Alimentary Pharmacology & Therapeutics|May 7, 2015
Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy--authors' replyH Schulze, P Esters, A Dignass
Journal of Crohn'S & Colitis|October 31, 2019
Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel DiseaseAyşegül Aksan, M Wohlrath, Tariq H Iqbal, et al.
Transplantation Proceedings|March 31, 2004
CMV, EBV, HHV6, and HHV7 infections after intestinal transplantation without specific antiviral prophylaxisA Pascher, J Klupp, R J Schulz, et al.
Alimentary Pharmacology & Therapeutics|September 8, 2017
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' replyA Aksan, H Işık, H H Radeke, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2017
Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel diseaseA Aksan, H Işık, H H Radeke, et al.
Alimentary Pharmacology & Therapeutics|June 17, 2017
Editorial: which iron preparation for patients with IBD? Authors' replyA Aksan, H Işık, H H Radeke, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2017
Letter: inconsistency in reporting of hypophosphataemia after intravenous iron-authors' replyA Aksan, H Işık, H H Radeke, et al.
Gastroenterology|May 1, 1995
Delivery and fate of oral mesalamine microgranules within the human small intestineP H Layer, H Goebell, J Keller, et al.
The Journal of Clinical Investigation|July 1, 1994
Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathwayA Dignass, K Lynch-Devaney, H Kindon, et al.
Pageof 6